Context Stem cell therapy is rapidly developing and has generated excitement and promise
as well as confusion and at times contradictory results in the lay and scientific literature …

Multiple sclerosis (MS) is an autoimmune, chronic, progressive disease leading to a
combination of inflammation, demyelination, and neurodegeneration throughout the central …

Background Strong immunosuppression, including chemotherapy and immune-depleting
antibodies followed by autologous haemopoietic stem-cell transplantation (aHSCT), has …

Autologous haematopoietic stem cell transplantation (aHSCT) is gaining traction as a
valuable treatment option for patients affected by severe multiple sclerosis (MS), particularly …

Intense immunosuppression followed by autologous haematopoietic stem-cell
transplantation has been assessed over the past few years as a possible new therapeutic …

Schizophrenia seems to be a heterogeneous disorder. Emerging evidence indicates that
low level neuroinflammation (LLNI) may not occur infrequently. Many infectious agents with …

Neuroinflammation is a well-recognized consequence of subarachnoid hemorrhage (SAH),
and may be responsible for important complications of SAH. Signaling by Toll-like receptor 4 …

Autologous hematopoietic stem cell transplantation (aHSCT) is a highly efficient treatment of
multiple sclerosis (MS), and hence it likely normalizes pathological and/or enhances …

Neurological disorder is a general term used for diseases affecting the function of the brain
and nervous system. Those include a broad range of diseases from developmental …

Background: A cohort of patients with poor-prognosis multiple sclerosis (MS) underwent
chemotherapy-based immune ablation followed by immune reconstitution with an …